Pharmacists in Baldwin, New York


14 Pharmacists found in Baldwin
female pharmacist

Dr. Amy A Lee, PHARMD


Pharmacist
944 Merrick Rd, Baldwin, NY 11510
516-223-1604    

female pharmacist

Mrs. Athena Konstantinakos, RPH


Pharmacist
668 Sunrise Hwy, Baldwin, NY 11510
516-867-6260    

male pharmacist

Mr. Bhikhu Patel


Pharmacist
944 Merrick Rd, Baldwin, NY 11510
516-223-1604     516-223-3508



male pharmacist

Mr. Dini Philip, RPH


Pharmacist
951 Atlantic Ave, Baldwin, NY 11510
516-223-8233    

male pharmacist

Dr. Dustin Brandon, PHARMD, RPH


Pharmacist
634 Lincoln St, Baldwin, NY 11510
516-242-9695    

female pharmacist

Edith S Bruno, PHARMACIST


Pharmacist
668 Sunrise Hwy, Baldwin, NY 11510
516-867-6260     516-867-0242

female pharmacist

Mrs. Elisa E Deligiannis, BS


Pharmacist
951 Atlantic Ave, Baldwin, NY 11510
516-223-8392     516-223-8342

female pharmacist

Irene Apostolou, RPH


Pharmacist
2360 Milburn Ave, Baldwin, NY 11510
917-650-6841    

female pharmacist

Marianna Shooshani


Pharmacist
944 Merrick Rd, Baldwin, NY 11510
516-223-1604     516-223-3508

male pharmacist

Patrick Wu


Pharmacist
951 Atlantic Ave, Baldwin, NY 11510
516-223-8233    

female pharmacist

Soniya Sajan


Pharmacist
951 Atlantic Ave, Baldwin, NY 11510
516-223-8233    

female pharmacist

Tracey Hodurski, RPH


Pharmacist
3278 Bertha Dr, Baldwin, NY 11510
516-761-7040    

female pharmacist

Wei Chien Hsieh, PHARM D


Pharmacist
951 Atlantic Ave, Baldwin, NY 11510
516-223-8233    

female pharmacist

Zaiba Sharieff


Pharmacist
951 Atlantic Ave, Baldwin, NY 11510
516-223-8233    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.